Lv7
4228 积分 2024-11-25 加入
History and Evolution of Innovations in Clinical Pharmacology
8天前
已完结
A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer
2个月前
已完结
Beyond single-dose human mass balance study: minimizing subject confinement and enabling true steady-state assessment with a novel multiple-dose design proposal
2个月前
已关闭
Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
4个月前
已完结
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
4个月前
已完结
Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
5个月前
已完结
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview
6个月前
已完结
Vascular endothelial growth factor (VEGF) – a valuable serum tumour marker in patients with colorectal cancer?
6个月前
已完结
Abstract 2734: RC148, a novel bispecific antibody targeting PD-1 and VEGF for cancer immunotherapy
6个月前
已关闭
1166P A phase I study of JS207, a PD-1/VEGF bispecific antibody, in patients with advanced malignancies
6个月前
已完结
皖公网安备34019202002308
